|
Our Director had a very interesting visit to the Gerresheimer Vaerloese, Denmark and followed up Gerresheimer Boleslawiec, Poland and participate in the GPP Pharmaday Celebrations in September'11. We look forward to very strong partnership with Gerresheimer Plastic Packaging Group as we go forward into the future.
Our Director was at the CphI'2011 in Frankfurt. Our principals OWEN MUMFORD LTD., GERRESHEIMER , ROVIPHARM, REMY & GEISER, UNILIFE & SAFETY SYRINGES were participating in this truly International Show as Exhibitors. It gave our Director the perfect opportunity for networking and evaluating new potential opportunities as we go forward. The benefits of this visit will flow as we move into the future.
We along with our Principals OWEN MUMFORD LTD., UK will be participating at the NDDS India 2011 organized by UBM India Conference and to be held from 11-12th August'2011 at the Holiday Inn, Mumbai Airport, Mumbai.
Our Director had a very interesting visit to the PHARMAPACK'2011 in Paris. It was an excellent Show as always and we look forward to a lot of follow-up developments as we go forward into the future.
We had the OWEN MUMFORD International Non-Group Business Team visiting our Offices to discuss our India Strategy for the Owen Mumford branded product business. We look forward to strengethening our partnership with OM as we go into the future.
We successfully began commercial deliveries of 'OPHELIA' the SUMATRIPTAN Auto-injector from OWEN MUMFORD LTD. It was truly a proud moment for all of us.
Our Director had a very interesting visit to the MEDICA'2010 in Dusseldorf from the 17th - 19th of November'2010. It was an excellent Show as always and we look forward to a lot of follow-up developments as we go forward into the future.
We would like to announce the receipt of the approval of the CDSCO, Directorate General of Health Services, Ministry of Health & Family Welfare, Government of India for the Marketing of UNIFINE Brand of Pentips in India. We look forward to offering the UNIFINE Pentips from OWEN MUMFORD LTD. our Principals to our Valued Pharmaceutical Customers. As we go along we will also set-up a Stock & Distribution Network in India since we forsee a huge potential Demand for the UNIFINE Pentip at the retail level sales too.
A very successful participation in Collaboration with Owen Mumford Ltd.,UK our Principals at the NextGen'2010, Innovation in Generics Symposium held at the West Inn Hotel in Mumbai on 24th-25th June'2010. Mr. Craig Thompson & Mr. Artur Plotnikow Account Managers from Owen Mumford were present during the Symposium. We expect positive reactions to our Participation and our Committment to offering Innovative Drug Delivery Device Solutions to the Indian Pharmaceutical Companies as they evolve into the future.
In May'10, WOCKHARDT LTD., our esteemed customer announced the re-launch of their EPO Brand, 'Wepox Safe', with a one of its kind Syringe Safety Device " Ultrasafe Passive " provided by us with the pro-active support of our Principals, Safety Syringes Inc. , USA who are World Leaders in their field and whom we Exclusively represent in India. We wish Wockhardt all the best into the future!!.
We are proud to have entered into an exclusive agreement with Unilife Medical Solutions Ltd. for India to market the 1ml Unitract (TM) Insulin and Clinical Safe Range Plastic Disposable Syringes with proprietory automatic needle retraction technology. We see an excellent opportunity in India for introducing the Unitract (TM) range of 1mL safety syringes for use within local healthcare facilities. Indian healthcare workers remain at significant risk of exposure to bloodborne pathogens due to needlestick injuries. This is a grave national concern that needs better management. Given the high standards of many Indian healthcare facilities and the desire for local pharmaceutical companies to gain a competitive advantage, we believe Unilife is well positioned to build quality relationships with local government and industry leaders.
We look forward to a successful partnership with Unilife into the future.
We are proud to be associated with SUN PHARMACEUTICAL INDUSTRIES LTD. and look forward to a long term association with them into the future. They have launched the "EXAPRIDE' Pen from OWEN MUMFORD LTD./UK with the Drug EXAPRIDE (Exenatide) for Type 2 Diabetics in India. We look forward to SUN PHARMACEUTICAL INDUSTRIES LTD. revolutionising the treatment for Type 2 Diabetics, in turn making a difference to the people of India and wish them all the very best in the years to come.
Successful visit to the CphI'2009 in Madrid/Spain.
Successful visit to the Medica'2009 in Dusseldorf/Germany.
Successful Road Show in India from 30th November'2009 - 8th December'2009 accompanied by Mr. Alex Jaksch.
Vice President-Business Development at Safety Syringes Inc. & Dr. Arno Fries, Director, Product Management (Syringes) & Head of Syringe Sales-USA from Gerresheimer promoting special solutions in Safety Devices & Syringe Systems independently as also as a combination product.
Mr. Horst Fritzlar from Gerresheimer Tubular Glass Division visited India in August'09. Another successful visit.
Dr. Markus Piduhn & Mr. Horst Fritzlar visited India in July'09 for a review meeting and interaction with regard to various oppurtunities for GX Tubular Glass Division in India so as to pave a successful way forward.
Mr. Hasse Hjartved from Gerresheimer Primary Plastic Packaging Division & based in Denmark visited India in June'09. Successful meetings held with various Clients in India. Excellent progress made and we anticipate a successful end to 2009 with a few more projects going commercial.
We have formerly started offering Specialised Closure Solutions from Remy & Geiser Gmbh., Germany (www.remy-geiser.com) .. You may visit the Web Site to evaluate the range and thereafter reach out to us for your requirements.
Together with ROVIPHARM, France our Principals whom we now exclusively represent in India, we shall together achieve excellence in the field of providing dosing solutions to the Indian Pharmaceutical Companies .. a great oppurtunity for the CLINICARE/ROVIPHARM partnership to flourish!! Infact we are already in business!!
The begining of May'09 was also eventfull and a proud moment for CLINICARE...We would like to proudly announce the First project commercialisation in India with the support of our Principals ROVIPHARM, France for their 5ml Dosing Syringes with a Indian Pharmaceutical Company.
In the last week of April'09 we have opened our 2nd account, again with an Indian Pharmaceutical Company for the supply of Ultra Safe Passive the one of its kind Passive Needle Safety Device we offer from our Principals SSI, USA. The product launch is scheduled for June/July'09.
Mr. Horst Fritzlar, Director Sales Development, Asia GERRESHEIMER Tubular Glass Division visited India from 26th April Through 4th May'09. The time was successfully spent development New Business Relationships and adding value to existing supply partnerships with Pharmaceutical Companies in India.
Our Director had a very interesting visit to the Gerresheimer Tubular Glass Manufacturing facilities in Vineland, New Jersey, USA and the Moulded Glass Manufacturing facilities in Millville, New Jersey, USA in August'2008 followed
Our Director had a successful visit to the Gerresheimer Manufacturing facilities in Boleslawiec- Poland. He also attended the International CPHI Meet in Frankfurt in September-October'08.
In October'2008 our Director attended the PDA Congress in San Diego, USA. It was a very interesting meet on Pre-filled Syringes, cartridges & Drug Delivery Devices.
Clinicare wishes all its Customers in India a very Happy Diwali and a Prosperous New Year ahead.
In the week begining 13th October'2008, Mr. Hasse Hjartved the Export Area Manager (Primary Plastic Packaging) for Asia was visiting India. It gave us an oppurtunity to visit Clients in Mumbai & Hyderabad amongst other places.
May'08 was eventful for us as we would like to take great pleasure in announcing our tie-up for India with ROVIPHARM, France a Specialist in injection moulded plastic for the pharmaceutical and medical industries offering innovative solutions. ROVIPHARM also offers customised solutions in the form of development and industrialization of products specially engineered to a customers specific needs. We look forward to a successfull partnership with ROVIPHARM into the future.
On June 4th BIOCON LTD., our esteemed customer announced the launch of their Biotech Products ERYPRO Safe & NUFIL Safe, drugs primarily packaged in a Ready to Fill Syringe and secondary packaging in the form of the one of its kind Safety Device " Ultrasafe Passive " provided through us from our principals Safety Syringes Inc. , USA. Its the begining of a new partnership for us with Biocon into the future.
In the 1st week of June'08 we had a visit from Mr. Denis Marteau, Business Head at our Principals, Owen Mumford Ltd. for the OEM Drug Delivery Device Business. The outcome of his visit and subsequent meetings conducted with Industry Majors is that we can optimistically look forward into the future to announce more projects & partnerships in this directions with reputed Indian Pharmaceutical Companies who are looking at the World as their Market.
Our Director Mr. Jagdeep Shah visited the Pharmapack'08 in France. Our Principals GERRESHEIMER GMBH, Germany & SAFETY SYRINGES INC., U.S.A. were Exhibitors at this prestigious Show which took place on 6-7th February'08. The CEO of SAFETY SYRINGES INC., Mr. Christer Andreasson was a Speaker at the Event.
Mr. Hasse Hjartved, Gerresheimer Manager responsible for Asia will be visiting India in the week begining 24th March'2008.
During February/March'2007, AVENTIS PHARMA LTD, Mumbai launched their "LANTUS® 24 - Hour Insulin" in a Cartridge In India in conjunction with the AUTOPEN 24, a Re-usable Automatic Insulin Delivery Pen manufactured at the State of Art Facilities of our Principals "OWEN MUMFORD LTD., U.K."
On 23rd February'2007, SHREYA LIFE SCIENCES PVT. LTD., Mumbai launched their "RECOSULIN" brand of Cartridge Insulin In India in conjunction with the RECOSULIN Re-usable Insulin Autopen manufactured in UK at the State of Art Facilities of our Principals "OWEN MUMFORD LTD., U.K."
|